LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis ; volume:20 ; number:1 ; day:24 ; month:5 ; year:2020 ; pages:1-12 ; date:12.2020
Cancer cell international ; 20, Heft 1 (24.5.2020), 1-12, 12.2020
- Creator
-
Liu, Yanjie
Guo, Ruixia
Qiao, Yuhuan
Han, Liping
Liu, Mingzhu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-020-01278-9
- URN
-
urn:nbn:de:101:1-2020072921502217258665
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Liu, Yanjie
- Guo, Ruixia
- Qiao, Yuhuan
- Han, Liping
- Liu, Mingzhu
- SpringerLink (Online service)
Other Objects (12)
lncRNA CDKN2B-AS1 regulates collagen expression
LncRNA MCM3AP-AS1 regulates miR-142-3p/HMGB1 to promote LPS-induced chondrocyte apoptosis
LncRNA MAFG-AS1 is involved in human cancer progression
LncRNA SH3PXD2A-AS1 facilitates cisplatin resistance in non-small cell lung cancer by regulating FOXM1 succinylation
Niederländische Barkasse "A.S.1"
LncRNA ZNF674-AS1 drives cell growth and inhibits cisplatin-induced pyroptosis via up-regulating CA9 in neuroblastoma
LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathway
Regulation of overexpression lncRNA ATP2B1-AS1 on lung adenocarcinoma progression
Emerging roles of a pivotal lncRNA SBF2-AS1 in cancers
lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells
TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2
lncRNA GAS8-AS1 downregulates lncRNA UCA1 to inhibit osteosarcoma cell migration and invasion
lncRNA CDKN2B-AS1 regulates collagen expression
LncRNA MCM3AP-AS1 regulates miR-142-3p/HMGB1 to promote LPS-induced chondrocyte apoptosis
LncRNA MAFG-AS1 is involved in human cancer progression
LncRNA SH3PXD2A-AS1 facilitates cisplatin resistance in non-small cell lung cancer by regulating FOXM1 succinylation
Niederländische Barkasse "A.S.1"
LncRNA ZNF674-AS1 drives cell growth and inhibits cisplatin-induced pyroptosis via up-regulating CA9 in neuroblastoma
LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathway
Regulation of overexpression lncRNA ATP2B1-AS1 on lung adenocarcinoma progression
Emerging roles of a pivotal lncRNA SBF2-AS1 in cancers
lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells
TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2
lncRNA GAS8-AS1 downregulates lncRNA UCA1 to inhibit osteosarcoma cell migration and invasion
lncRNA CDKN2B-AS1 regulates collagen expression
LncRNA MCM3AP-AS1 regulates miR-142-3p/HMGB1 to promote LPS-induced chondrocyte apoptosis
LncRNA MAFG-AS1 is involved in human cancer progression
LncRNA SH3PXD2A-AS1 facilitates cisplatin resistance in non-small cell lung cancer by regulating FOXM1 succinylation
Niederländische Barkasse "A.S.1"
LncRNA ZNF674-AS1 drives cell growth and inhibits cisplatin-induced pyroptosis via up-regulating CA9 in neuroblastoma
LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathway
Regulation of overexpression lncRNA ATP2B1-AS1 on lung adenocarcinoma progression
Emerging roles of a pivotal lncRNA SBF2-AS1 in cancers
lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells
TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2